← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2014Last known activity
Oct 9, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 7 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT04513145Overall official - principal investigatorPhase 2/Phase 3Oct 9, 2020
- NCT04513145Lead sponsorPhase 2/Phase 3Oct 9, 2020
- NCT03713528Overall official - principal investigatorPhase 4Dec 1, 2018
- NCT03713528Lead sponsorPhase 4Dec 1, 2018
- NCT03540030Lead sponsorPhase 4Aug 31, 2016
- NCT02604537Overall official - principal investigatorPhase 4Nov 11, 2015
- NCT02604537Lead sponsorPhase 4Nov 11, 2015
- NCT02349542Lead sponsorPhase 4Jan 1, 2015
- NCT02226159Lead sponsorPhase 4Aug 1, 2014
- NCT02226159Overall official - principal investigatorPhase 4Aug 1, 2014
- NCT02586077Lead sponsorPhase 4Feb 1, 2014
- NCT02586077Overall official - principal investigatorPhase 4Feb 1, 2014
- NCT02586077Study directorPhase 4Feb 1, 2014
Details
- Last known activity
- Oct 9, 2020